AMA Finds Competition Decline Among Drug Middlemen

As expectations grow for congressional action to address questionable business practices of the pharmacy benefit manager (PBM) industry, the American Medical Association (AMA) today released an update to its analysis of market competition among PBMs that provide middlemen services in the drug supply chain and their vertical integration with health insurers.